Johnson &Johnson Near Deal for Drugmaker Pharmacyclics -FT
March 04 2015 - 3:53PM
Dow Jones News
Johnson & Johnson (JNJ) is nearing a deal to buy
Pharmacyclics Inc. (PCYC), a developer of cancer treatments, the
Financial Times reported Wednesday on its website, citing people
familiar with the matter.
A deal could be reached in the coming days, although talks could
still fall apart, the people told the FT.
Last month Bloomberg News, citing people with knowledge of the
matter, reported that J&J and Novartis AG (NVS) had shown
interest in buying Pharmacyclics.
Web site: www.ft.com
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2024 to May 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From May 2023 to May 2024